Evidence map›Paper›PMID 22048617›Full record

ArticleApplied microbiology and biotechnology2012

An erythromycin process improvement using the diethyl methylmalonate-responsive (Dmr) phenotype of the Saccharopolyspora erythraea mutB strain.

J Mark Weber, William H Cernota, Melissa C Gonzalez, Benjamin I Leach, Andrew R Reeves, Roy K Wesley

Abstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

J Mark WeberFermalogic, Inc, 920 North Franklin Street, Chicago, IL 60610, USA. mark.weber@fermalogic.com
William H Cernota
Melissa C Gonzalez
Benjamin I Leach
Andrew R Reeves
Roy K Wesley
Fermalogic (United States) · US

Funding

Metabolic engineering of the methylmalonyl-CoA node in S. erythreaR43GM079946 · NIGMS · FERMALOGIC, INC. · PI WEBER, J. MARK · 2007 to 2007
$380k
NIGMS NIH HHS GM079945NIGMS NIH HHS R43 GM079946
6 · The paper itself

Abstract

The Saccharopolyspora erythraea mutB knockout strain, FL2281, having a block in the methylmalonyl-CoA mutase reaction, was found to carry a diethyl methylmalonate-responsive (Dmr) phenotype in an oil-based fermentation medium. The Dmr phenotype confers the ability to increase erythromycin A (erythromycin) production from 250-300% when the oil-based medium is supplemented with 15 mM levels of this solvent. Lower concentrations of the solvent stimulated proportionately less erythromycin production, while higher concentrations had no additional benefit. Although the mutB strain is phenotypically a low-level erythromycin producer, diethyl methylmalonate supplementation allowed it to produce up to 30% more erythromycin than the wild-type (control) strain-a strain that does not show the Dmr phenotype. The Dmr phenotype represents a new class of strain improvement phenotype. A theory to explain the biochemical mechanism for the Dmr phenotype is proposed. Other phenotypes found to be associated with the mutB knockout were a growth defect and hyper-pigmentation, both of which were restored to normal by exposure to diethyl methylmalonate. Furthermore, mutB fermentations did not significantly metabolize soybean oil in the presence of diethyl methylmalonate. Finally, a novel method is proposed for the isolation of additional mutants with the Dmr phenotype.

Indexed as

Anti-Bacterial AgentsCulture MediaDrug ToleranceErythromycinFermentationGene DeletionMalonatesMetabolic EngineeringMethylmalonyl-CoA MutasePhenotypeSaccharopolysporaAnti-Bacterial AgentsCulture MediaErythromycinMalonatesMethylmalonyl-CoA Mutase

Identifiers

PMID22048617
PMCPMC3276693
OpenAlexW2171335812

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.